BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …

“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …

BACKGROUND Female patients undergoing anticancer treatment are at elevated risk of
adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI) …

This care pathway from the European Menopause and Andropause Society (EMAS)
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …

Normal levels of reactive oxygen species (ROS) play an important role in regulating follicular
growth, angiogenesis and sex hormone synthesis in ovarian tissue. When the balance …

The transition to menopause is associated with a changing hormonal milieu, leading to
bothersome menopausal symptoms in the short-term and chronic health problems in the …

Endocrine-disrupting chemicals (EDCs) are ubiquitous in daily life, but their harmful effects
on the human body have not been fully explored. Recent studies have shown that EDCs …

Reproductive hormones play a crucial role in the growth and maintenance of the
mammalian skeleton. Indeed, the biological significance for this hormonal regulation of …

This narrative review analyses the customization of Menopause Hormone Therapy in the
context of breast cancer risk in women with premature ovarian insufficiency (POI) and with …